• Mildronate-Derived Lipidoids Minimize Inflammation in mRNA D

  2026-06-12

  The referenced ACS Nano study unveils mildronate-derived cationic lipidoids as innovative lipid nanoparticle components for mRNA vaccine delivery, achieving potent immunogenic efficacy with notably reduced inflammatory side effects in preclinical models. This represents a significant advance for safer mRNA-based immunization strategies and translational research.

• Phosbind Biotin LC: Technical Guide for Western Blot Phospho

  2026-06-12

  Phosbind Biotin LC addresses the challenge of detecting phosphorylated proteins on PVDF membranes, especially when phospho-specific antibodies are insufficient or unavailable. It is specifically designed for Western Blot workflows and should not be used in aqueous-only protocols or situations requiring long-term storage of reagent solutions.

• Sulfachloropyridazine: Applied Workflows and Microbial Resea

  2026-06-11

  Sulfachloropyridazine stands out as a precision sulfonamide antibacterial agent for mechanistic and translational research. This article details advanced workflows, protocol parameters, and troubleshooting tips, emphasizing microbiota modulation, enzyme inhibition, and in vivo infection models.

• Tomivosertib and the Metabolic Control of Tumorigenesis

  2026-06-11

  Explore how Tomivosertib, a potent MNK1 inhibitor, uniquely enables researchers to dissect metabolic translation control in cancer and fasting states. This deep-dive article reveals novel assay strategies grounded in the latest translational science.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-06-10

  0.4% Trypan Blue Solution enables rapid, direct live/dead cell discrimination in research workflows where accurate cell viability measurement is essential. This azo dye for cell staining is not suitable for diagnostic or medical use but is established for cell counting and cytotoxicity assays in controlled laboratory environments.

• Biomimetic Nanoplatforms for Metastatic TNBC: Photothermal a

  2026-06-10

  This article examines the development of an intelligent biomimetic nanoplatform for metastatic triple-negative breast cancer (TNBC), integrating photothermal ablation with immune remodeling. The study demonstrates how targeted delivery and synergistic immune activation can overcome tumor recurrence and metastasis, offering a holistic approach to TNBC treatment.

• ABT-737: Advancing BCL-2 Inhibition for Translational Oncolo

  2026-06-09

  Explore how ABT-737, a leading BCL-2 protein inhibitor, is reshaping apoptosis research in cancer. This thought-leadership article bridges mechanistic insight, advanced imaging, validated protocols, and strategic guidance for translational researchers, while contextualizing ABT-737’s unique value in light of recent mitochondrial nanoscopy breakthroughs.

• JNJ-26481585 (Quisinostat): Epigenetic Targeting of TRIM21 i

  2026-06-09

  Explore how JNJ-26481585 (Quisinostat), a potent HDAC inhibitor, uniquely downregulates TRIM21 to overcome drug resistance in cancer research. This in-depth analysis offers advanced insights and practical guidance for leveraging epigenetic modulation in oncology.

• Anisomycin as a JNK Agonist: Protocols & Advanced Use-Cases

  2026-06-08

  Anisomycin (SKU B6674) is a potent JNK agonist uniquely suited for dissecting apoptosis, stress signaling, and synaptic plasticity. This article delivers actionable protocols, highlights cross-disciplinary breakthroughs, and shares troubleshooting strategies to maximize reproducibility with APExBIO's trusted reagent.

• Dronedarone (Multaq) in Atrial Fibrillation Treatment Resear

  2026-06-08

  Dronedarone (Multaq) stands out as a high-purity, workflow-compatible antiarrhythmic agent for atrial fibrillation and flutter research. This article bridges experimental protocols, troubleshooting, and the latest mechanistic insights to help cardiac arrhythmia researchers optimize reproducibility and data quality using APExBIO’s validated dronedarone.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Receptor Bindi

  2026-06-07

  Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides can enhance the binding of the SARS-CoV-2 spike protein to its cellular receptors, particularly AXL. Unlike shorter peptide derivatives, Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) did not increase spike–AXL binding, highlighting sequence-dependent modulation within the renin-angiotensin system and suggesting new angles for COVID-19 pathogenesis research.

• 2-Deoxy-D-glucose: Applied Glycolysis Inhibition in Research

  2026-06-06

  2-Deoxy-D-glucose (2-DG) is a benchmark metabolic oxidative stress inducer and glycolysis inhibitor, enabling precision modulation of cellular energy pathways. Recent protocols demonstrate its power for dissecting immune-metabolic crosstalk and enhancing cancer research workflows.

• Everolimus (RAD001) in Cancer Research: Precision, Pitfalls,

  2026-06-05

  Discover how Everolimus (RAD001) enables high-precision mTOR pathway inhibition in cancer research. This in-depth review reveals nuanced insights for optimizing apoptosis and proliferation assays, with a focus on experimental rigor and actionable protocol refinements.

• Protease Inhibitor Cocktail EDTA-Free: Preserving Antigen In

  2026-06-05

  Explore how Protease Inhibitor Cocktail EDTA-Free enhances protein extraction by preserving antigen presentation critical for immunotherapy studies. This article uniquely bridges protease inhibition with advanced applications in T cell–dependent cancer research.

• Hexamethonium Bromide: Precision Tool for Neuronal-Type Nico

  2026-06-04

  Hexamethonium Bromide, a selective antagonist of neuronal-type nicotinic AChRs, enables high-resolution dissection of autonomic ganglia function and cholinergic neurotransmission in cardiovascular and neurophysiological studies. Its role is pivotal in modeling sex-dependent hypertension and refining experimental workflows for autonomic nervous system research.

453 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page